Navjeewan Khosla joined Novo Holdings Asia in August 2021 and is a Partner there, focusing on deal sourcing and execution and on managing the portfolio, primarily in China, India and Southeast Asia. Before Novo Holdings he was a Director at Quadria Capital, a mid-market healthcare private equity firm covering India and Southeast Asia, and before that Managing Director at Fosun, working on private and public healthcare investment opportunities across Asia-Pacific. He started his investment career at Merrill Lynch in Hong Kong and moved to UBS Global Asset Management in Singapore. He holds an MBA from IIM Ahmedabad and a Bachelor of Technology from IIT Kharagpur.
Education
MBA, Indian Institute of Management (IIM) Ahmedabad
Bachelor of Technology, Indian Institute of Technology (IIT) Kharagpur
Previous Experience
Merrill Lynch, Hong Kong
UBS Global Asset Management, Singapore
Fosun - Managing Director, healthcare investment across Asia-Pacific
Quadria Capital - Director, healthcare private equity in India and South East Asia
Notable Investments
Surya HospitalsSCHOTT Poonawalla
Board Seats
Surya Hospitals
Career Timeline
2021
Joins Novo Holdings Asia in August 2021.
2025
Quoted as Partner at Novo Holdings Asia in the firm's announcement of its investment in SCHOTT Poonawalla.
2026
Named in Novo Holdings' announcement that he will join the board of directors of Surya Hospitals.